Indication
Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis
Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis is a rare, distinct autoimmune subtype of generalized myasthenia gravis affecting the peripheral nervous system and neuromuscular junction. Read more about Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis
4 drugs 4 manufacturers
Drugs that treat it
Common Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis therapies.
RYSTIGGO (rozanolixizumab-noli)
UPLIZNA (inebilizumab-cdon)
IMAAVY (nipocalimab-aahu)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAnti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis is a rare, distinct autoimmune subtype of generalized myasthenia gravis affecting the peripheral nervous system and neuromuscular junction.
It is mediated predominantly by pathogenic IgG4 autoantibodies directed against MuSK, a receptor essential for agrin-mediated acetylcholine receptor clustering and postsynaptic structural integrity.
Unlike typical acetylcholine receptor-associated disease, this form demonstrates a strong female predominance and is clinically characterized by severe, rapidly progressive muscle weakness that preferentially involves the bulbar, facial, neck, and respiratory musculature, frequently carrying a high risk of life-threatening myasthenic crisis and muscle atrophy.
- nih.gov
Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis is a rare, distinct autoimmune subtype of generalized myasthenia gravis affecting the peripheral nervous system and neuromuscular junction
- nih.gov
Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis is a rare, distinct autoimmune subtype of generalized myasthenia gravis affecting the peripheral nervous system and neuromuscular junction Unlike typical acetylcholine receptor-associated disease, this form demonstrates a strong female predominance and is clinically characterized by severe, rapidly progressive muscle weakness that preferentially involves the bulbar, facial, neck, and respiratory musculatu...
- frontiersin.org
Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis is a rare, distinct autoimmune subtype of generalized myasthenia gravis affecting the peripheral nervous system and neuromuscular junction It is mediated predominantly by pathogenic IgG4 autoantibodies directed against MuSK, a receptor essential for agrin-mediated acetylcholine receptor clustering and postsynaptic structural integrity
- nih.gov
It is mediated predominantly by pathogenic IgG4 autoantibodies directed against MuSK, a receptor essential for agrin-mediated acetylcholine receptor clustering and postsynaptic structural integrity
- nih.gov
Unlike typical acetylcholine receptor-associated disease, this form demonstrates a strong female predominance and is clinically characterized by severe, rapidly progressive muscle weakness that preferentially involves the bulbar, facial, neck, and respiratory musculature, frequently carrying a high risk of life-threatening myasthenic crisis and muscle atrophy
- nih.gov
Unlike typical acetylcholine receptor-associated disease, this form demonstrates a strong female predominance and is clinically characterized by severe, rapidly progressive muscle weakness that preferentially involves the bulbar, facial, neck, and respiratory musculature, frequently carrying a high risk of life-threatening myasthenic crisis and muscle atrophy
- mdpi.com
Unlike typical acetylcholine receptor-associated disease, this form demonstrates a strong female predominance and is clinically characterized by severe, rapidly progressive muscle weakness that preferentially involves the bulbar, facial, neck, and respiratory musculature, frequently carrying a high risk of life-threatening myasthenic crisis and muscle atrophy
Personalize your experience
Follow Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.